Reapplix Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers. | |||
Founding Date | Founding Date 2019 | Founding Date 2008 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Palo Alto, US HQ Durham, US Redwood City, US | Locations Birkerød, DK HQ Southlake, US | Locations Woburn, US HQ Aurora, US |
Employees | Employees 203 | Employees 36 | Employees N/A |
Funding | |||
Latest funding round | Latest funding round $ 270m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 6 years ago) |
Total funding raised | Total funding raised $ 450.5m | Total funding raised $ 1.7m | Total funding raised $ 10m |
Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers.
View company
IM Therapeutics is a company that develops personalized immuno-therapeutic drugs.
View company